Sorrento Therapeutics Inc... (SRNE)

AI Score

Unlock

0.00

-0.00 (-100.00%)

At close: Apr 04, 2025, 9:47 AM

Sorrento Therapeutics Income Statement

Chart Mode

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012	FY 2011	FY 2010	FY 2009	FY 2008	FY 2007	FY 2006	FY 2005	FY 2004	FY 2003
Period Ending	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014	Dec 31, 2013	Dec 31, 2012	Dec 31, 2011	Dec 31, 2010	Dec 31, 2009	Dec 31, 2008	Dec 31, 2007	Dec 31, 2006	Dec 31, 2005	Dec 31, 2004	Dec 31, 2003
Revenue	62.84M	52.9M	39.99M	31.43M	21.19M	151.86M	8.15M	4.59M	3.83M	460.15K	583.77K	529.18K	682.57K	5.41K	n/a	n/a	n/a	n/a	n/a	n/a
Cost of Revenue	33.45M	13.03M	9.94M	12.24M	10.07M	11.03M	3.7M	1.95M	2.04M	4.44K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Gross Profit	29.39M	39.87M	30.05M	19.2M	11.12M	140.83M	4.46M	2.64M	1.78M	455.71K	583.77K	529.18K	682.57K	5.41K	n/a	n/a	n/a	n/a	n/a	n/a
Operating Income	-504.31M	-368.05M	-201.53M	-195.18M	-129.48M	52.34M	-59.9M	-74M	-34.74M	-21.67M	-4.85M	-3.24M	-1.81M	-954.12K	-190.51K	-240.63K	-439.29K	-308.03K	-763	-763
Interest Income	n/a	n/a	24K	1.09M	921K	241K	272K	24K	12K	9.62K	7.3K	5.95K	3.79K	11.86K	1.61K	9.00	n/a	n/a	n/a	n/a
Pretax Income	-561.75M	-462.53M	-310.58M	-359.58M	-213.78M	15.31M	-64.83M	-13.76M	-36.36M	-21.91M	-4.85M	-3.24M	-1.81M	-942.27K	n/a	-270.63K	n/a	-616.06K	n/a	n/a
Net Income	-572.84M	-429.01M	-308.57M	-359.1M	-203.54M	9.06M	-60.92M	-45.81M	-34.66M	-21.91M	-4.85M	-3.24M	-1.81M	-942.27K	-188.9K	-270.62K	-439.29K	-308.03K	-763	-763
Selling & General & Admin	182.34M	196.86M	116.18M	103.56M	63.64M	32.96M	22.18M	20.13M	9.99M	6.32M	1.61M	1.2M	1.1M	543.95K	190.51K	240.63K	439.29K	n/a	n/a	n/a
Research & Development	221.23M	206.92M	111.34M	106.88M	76.96M	55.53M	42.17M	31.34M	23.98M	9.02M	3.83M	2.57M	1.39M	410.17K	n/a	n/a	n/a	n/a	n/a	n/a
Other Expenses	130.14M	4.14M	4.05M	3.94M	3.01M	2.61M	845K	1.16M	2.35M	804.07K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-308.03K	-763	-763
Operating Expenses	533.7M	407.92M	231.57M	214.38M	140.6M	88.49M	64.35M	52.63M	36.31M	16.14M	5.44M	3.77M	2.49M	954.12K	190.51K	240.63K	439.29K	-308.03K	-763	-763
Interest Expense	8.57M	10.22M	20.18M	36.14M	57.63M	4.98M	1.61M	1.65M	1.63M	253.19K	7.3K	5.95K	3.79K	11.86K	1.61K	n/a	n/a	n/a	n/a	763.00
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	-5.37M	-2.04M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	567.15M	420.95M	241.51M	226.61M	150.67M	99.52M	68.05M	54.58M	38.36M	16.14M	5.44M	3.77M	2.49M	954.12K	190.51K	240.63K	439.29K	-308.03K	-763	-763
Income Tax Expense	-2.42M	-33.52M	-2.01M	-473K	-6.27M	-36.04M	-896K	36.31M	-1.7M	9.62K	14.6K	11.9K	7.57K	23.71K	-1.61K	-9	439.29K	-308.03K	763.00	763.00
Shares Outstanding (Basic)	419.31M	294.77M	229.82M	140.51M	106.15M	69.74M	50.36M	36.91M	26.68M	15.05M	11.41M	9.92M	8.83M	6.08M	378.02K	257.93K	28.41K	28.41K	28.41K	28.41K
Shares Outstanding (Diluted)	419.31M	294.77M	229.82M	140.51M	106.15M	70.38M	50.36M	36.91M	26.68M	15.05M	11.41M	9.92M	8.83M	6.08M	378.02K	257.93K	28.41K	28.41K	28.41K	28.41K
EPS (Basic)	-1.37	-1.46	-1.34	-2.56	-1.92	0.13	-1.21	-1.24	-1.3	-1.46	-0.42	-0.33	-0.2	-0.15	-0.5	-1.05	-15.46	-10.84	-0.03	-0.03
EPS (Diluted)	-1.37	-1.46	-1.34	-2.56	-1.92	0.13	-1.21	-1.24	-1.3	-1.46	-0.42	-0.33	-0.2	-0.15	-0.5	-1.05	-15.46	-10.84	-0.03	-0.03
EBITDA	-539.93M	-435.99M	-275.69M	-308.39M	-147.1M	27.38M	-60.34M	-9.74M	-31.55M	-20.37M	-4.55M	-3.08M	-1.78M	-939.51K	-187.29K	-270.62K	-439.29K	-308.03K	-763	-763
EBIT	-553.17M	-452.3M	-290.42M	-324.53M	-156.15M	20.3M	-63.66M	-8.07M	-34.73M	-21.66M	-4.84M	-3.24M	-1.81M	-942.27K	n/a	n/a	n/a	n/a	n/a	n/a
Depreciation & Amortization	13.24M	16.32M	14.71M	15.04M	9.05M	7.08M	2.88M	2.37M	3.18M	1.29M	293.3K	159.22K	23.41K	2.75K	3.23K	-29.99K	n/a	n/a	n/a	n/a